En Es
Categories

Industry News

Canon Medical Systems Initiates Collaborative Research On AI in MR Imaging

By Medimaging International staff writers
05 Apr 2018

Image: Canon Medical Systems has initiated collaborative research on the application of AI-based technology in magnetic resonance imaging (Photo courtesy of iStock).Canon Medical Systems Corporation (Otawara, Tochigi Prefecture, Japan), along with Kumamoto University (Kumamoto Prefecture, Kurokami, Japan) and the University of Bordeaux (Bordeaux, Nouvelle-Aquitaine, France), has initiated collaborative research on the application of Deep Learning Reconstruction (DLR), an Artificial Intelligence (AI)-based technology in magnetic resonance (MR) imaging.

DLR is a reconstruction technology that utilizes deep learning technology to eliminate noise from images. The technology analyzes the relationship between noisy and less noisy images using a computer-generated model, making it possible to eliminate noise from newly acquired images. DLR is capable of acquiring high-resolution images, as well as allowing ultra-high-resolution images to be acquired more quickly in comparison to conventional imaging methods. As a result, the potential applications of this ultra-high-resolution imaging technology in the clinical setting have been attracting significant interest.

Additionally, in comparison to a standard smoothing filter, the noise elimination method employed in DLR causes only a slight reduction in image quality, and signal variation in organ parenchyma is minimized. This improves the image quality and helps to increase accuracy in quantitative analysis, which is easily affected by noise. Hence, DLR is considered as a major technological advance that can dramatically change how MRI examinations will be performed in the future. The combination of the latest AI technology with next-generation MRI scanners is expected to be useful in eliminating noise and improving image quality, as well as in a wide variety of MR-related fields.

“DLR has the potential to transform the conventional concept of MR imaging and is expected to allow the acquisition of super-high-resolution images in a shorter time and contribute to more accurate quantitative analysis,” said Professor Yasuyuki Yamashita of the Department of Diagnostic Radiology, Faculty of Life Science, Kumamoto University.

“When DLR is used in combination, the ultra-high-resolution images acquired using the latest 3-T MRI system from Canon Medical Systems (installed last November) are comparable to images acquired using a 7-T MRI system. This suggests that DLR may be able to take the place of some high-field conventional MRI studies,” added Professor Vincent Dousset, Institut de Bio-Imagerie Université de Bordeaux, Chef de Service Neuro-Imagerie CHU de Bordeaux.

“We are very proud to have started this cutting-edge collaborative research which will lead to the development of next-generation MRI technology at leading medical institutions both in and outside Japan. We anticipate that this research will prove to be of great value by providing higher-resolution images for clinical diagnosis,” said President Takiguchi of Canon Medical Systems Corporation.



E-mail Print
FaceBook Twitter Google+ Linked in

CANON

Canon U.S.A., Inc. provides digital imaging solutions for the healthcare sector, including digital detectors, digital radiography / fluoroscopy solutions, mobile & portable solutions, acquisition carts, and software solutions.
More info

More articles about CANON

07 Nov 2019
CT System Receives FDA Clearance for AI-Based Image Reconstruction Technology
Canon Medical Systems USA, Inc. (Tustin, CA, USA; www.us.medical.canon) has received 510(k) clearance for its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion Precision, further expanding access to its new deep convolutional neural network (DCNN) image reconstruction technology. The technology, which is now available on Canon’s Aquilion Precision and Aquilion ONE/GENESIS Edition CT systems, uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal, thus improving CT image reconstruction.
Read More
06 Jul 2019
AI-Based Image Reconstruction Solution Receives FDA Clearance
Canon Medical Systems USA, Inc. has received 510(k) clearance from the FDA for its new deep convolutional neural network (DCNN) image reconstruction technology.
Read More
09 Jan 2018
Toshiba Medical Systems Changes Name to Canon Medical Systems
The official corporate name of Toshiba Medical Systems Corporation has been changed to Canon Medical Systems Corporation. The name change follows the completion of procedures for obtaining regulatory approval for integration with the Canon Group after the company officially became a subsidiary of Canon Inc. in December 2016. Similarly, Toshiba America Medical Systems, now a Canon group company, has been officially named as Canon Medical Systems USA, Inc.
Read More
22 Dec 2016
Canon Completes Acquisition of Toshiba Medical
Japanese electronics manufacturer Canon Inc. has completed its acquisition of Toshiba Medical Systems Corp., a medical unit of Toshiba Corp. that provides medical imaging products and solutions. Canon has received the necessary clearance from competition regulatory authorities to make Toshiba Medical its subsidiary in a USD 54.7 billion deal.
Read More

Additional news

20 May 2022
Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business
QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.
Read More
16 May 2022
Medtronic Completes Acquisition of Intersect ENT to Add Innovative Sinus Implants to ENT Portfolio
Medtronic plc (Dublin, Ireland) has completed the acquisition of Intersect ENT (Menlo Park, CA, USA), thereby expanding the company's comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps.
Read More
12 May 2022
Global Lateral Flow Assays Market to Surpass USD 11.5 Billion by 2032 Due to Evolving Applications
The global lateral flow assays market is projected to register a CAGR of 4.7% during 2022-2032 to surpass USD 11.7 billion by the end of 2032, driven by the growing prevalence of influenza, STDs, and tuberculosis worldwide and rising awareness among people about the availability of POCT kits.
Read More
11 May 2022
Global Rapid Test Kits Market Driven by Immunoassay and Chromatography-Based Tests
The global rapid test kits market size was valued at more than USD 25.50 billion in 2021 and is expected to register a CAGR of 8.1% over the 2019-2030 period to surpass USD 52 billion in 2030, driven primarily by the increasing prevalence of various infectious diseases.
Read More
03 May 2022
Meridian Acquires Euprotein to Further Expand Recombinant Protein Capabilities
Meridian Bioscience, Inc. (Cincinnati, OH, USA) has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. (North Brunswick Township, NJ, USA).
Read More
02 May 2022
Globe Scientific Acquired by L Squared Capital Partners
Globe Scientific (Mahwah, NJ, USA), a provider of laboratory consumable supplies, has been acquired by L Squared Capital Partners (Newport Beach, CA, USA), marking its third acquisition as part of GSI Group Holdings.
Read More
29 Apr 2022
GE Healthcare and Medtronic Collaborate to Improve Product Access for ASCs and OBLs
GE Healthcare (Chicago, IL, USA) and Medtronic (Doral, FL, USA) have entered into a collaboration focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs) that will allow customers to access extensive product portfolios, financial solutions, and exceptional service.
Read More
22 Apr 2022
Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026
The global diagnostic imaging market is projected to grow at a CAGR of 4.9% from an estimated USD 27.5 billion in 2022 to over USD 33 billion by 2026, driven by technological advancements, favorable demographic factors in the developed regions, growing access to healthcare and rising income levels of the middle class population in the developing regions.
Read More
22 Apr 2022
Global Electrosurgery Market to Reach Almost USD 6 Billion by 2026
The global electrosurgery market is projected to grow at a CAGR of 3.6% from an estimated USD 5 billion in 2022 to almost USD 6 billion by 2026, driven by the rapidly rising number of surgeries being performed globally, an aging population, and increasing prevalence of various chronic diseases.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions